Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.
Read Full NewsIn patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.
Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.
In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.
1.
The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.
2.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
3.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
4.
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.
5.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
1.
Managing Hematoma: A Guide to Prevention and Treatment
2.
The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Exploring the Benefits of Endari: How This Natural Remedy Can Help You Live a Healthier Life
5.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
4.
Thromboprophylaxis In Medical Settings
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge